Rona M. M. Mackie
#132,448
Most Influential Person Now
Rona M. M. Mackie's AcademicInfluence.com Rankings
Rona M. M. Mackiephilosophy Degrees
Philosophy
#6506
World Rank
#9551
Historical Rank
Logic
#3660
World Rank
#4853
Historical Rank
Rona M. M. Mackiebiology Degrees
Biology
#8834
World Rank
#11967
Historical Rank
Immunology
#513
World Rank
#530
Historical Rank
Download Badge
Philosophy Biology
Rona M. M. Mackie's Degrees
- Bachelors Biology University of California, Berkeley
- Doctorate Medicine Stanford University
Similar Degrees You Can Earn
Why Is Rona M. M. Mackie Influential?
(Suggest an Edit or Addition)Rona M. M. Mackie's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma: final results of EORTC 18991, a randomised phase III trial (2008) (474)
- Genome-wide association study identifies three loci associated with melanoma risk (2009) (444)
- Diagnosis and Treatment of Early Melanoma: NIH Consensus Development Panel on Early Melanoma (1992) (435)
- Thin Stage I Primary Cutaneous Malignant Melanoma (1988) (419)
- High-risk melanoma susceptibility genes and pancreatic cancer, neural system tumors, and uveal melanoma across GenoMEL. (2006) (401)
- Epidemiology of invasive cutaneous melanoma (2009) (385)
- Features associated with germline CDKN2A mutations: a GenoMEL study of melanoma-prone families from three continents (2006) (384)
- Benign melanocytic naevi as a risk factor for malignant melanoma. (1986) (331)
- Sentinel Lymph Node Biopsy in Cutaneous Melanoma: The WHO Melanoma Program Experience (2000) (328)
- Revised U.K. guidelines for the management of cutaneous melanoma 2010 (2010) (316)
- CANCER, WARTS, AND SUNSHINE IN RENAL TRANSPLANT PATIENTS A Case-control Study (1984) (294)
- PERSONAL RISK-FACTOR CHART FOR CUTANEOUS MELANOMA (1989) (291)
- Post-surgery adjuvant therapy with intermediate doses of interferon alfa 2b versus observation in patients with stage IIb/III melanoma (EORTC 18952): randomised controlled trial (2005) (291)
- Fatal melanoma transferred in a donated kidney 16 years after melanoma surgery. (2003) (280)
- Risk of cutaneous melanoma associated with pigmentation characteristics and freckling: Systematic overview of 10 case‐control studies (1995) (255)
- Genome-wide association study identifies three new melanoma susceptibility loci (2011) (252)
- Sun exposure and melanoma risk at different latitudes: a pooled analysis of 5700 cases and 7216 controls (2009) (250)
- Staphylococcal colonization in atopic dermatitis and the effect of topical mupirocin therapy (1988) (246)
- Effect of long-term adjuvant therapy with interferon alpha-2a in patients with regional node metastases from cutaneous melanoma: a randomised trial (2001) (236)
- Incidence of and survival from malignant melanoma in Scotland: an epidemiological study (2002) (229)
- Revised UK guidelines for the management of cutaneous melanoma 2010. (2010) (211)
- Audit of public education campaign to encourage earlier detection of malignant melanoma. (1992) (205)
- Severe sunburn and subsequent risk of primary cutaneous malignant melanoma in scotland. (1982) (204)
- Genome-wide meta-analysis identifies five new susceptibility loci for cutaneous malignant melanoma (2015) (199)
- Risk of cutaneous melanoma associated with a family history of the disease (1995) (196)
- Photodynamic therapy for large or multiple patches of Bowen disease and basal cell carcinoma. (2001) (195)
- Lack of effect of pregnancy on outcome of melanoma (1991) (188)
- Adjuvant interferon alpha 2b in high risk melanoma – the Scottish study (2001) (177)
- Postoperative Depression of Tumour-directed Cell-mediated Immunity in Patients with Malignant Disease (1972) (176)
- Selection criteria for genetic assessment of patients with familial melanoma. (2009) (168)
- Intralesional injection of herpes simplex virus 1716 in metastatic melanoma (2001) (163)
- Photodynamic therapy for basal cell carcinoma: effect of tumor thickness and duration of photosensitizer application on response. (1998) (155)
- Results of adjuvant interferon study In WHO melanoma programme (1994) (154)
- A randomized trial of adjuvant chemotherapy and immunotherapy in cutaneous melanoma (1982) (151)
- Cutaneous malignant melanoma in Scotland: incidence, survival, and mortality, 1979-94 (1997) (150)
- Cutaneous malignant melanoma, Scotland, 1979-89 (1992) (148)
- Genome-wide association study identifies a new melanoma susceptibility locus at 1q21.3 (2011) (146)
- Fluorescent lights, ultraviolet lamps, and risk of cutaneous melanoma. (1988) (145)
- Histopathologic diagnosis of dysplastic nevi: concordance among pathologists convened by the World Health Organization Melanoma Programme. (1991) (144)
- Clinical recognition of early invasive malignant melanoma. (1990) (142)
- Incidence, risk factors and prevention of melanoma. (1998) (133)
- EORTC Melanoma Group. Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma: final results of EORTC 18991, a randomised phase III trial. (2008) (132)
- Diagnostic and neural analysis of skin cancer (DANAOS). A multicentre study for collection and computer‐aided analysis of data from pigmented skin lesions using digital dermoscopy (2003) (131)
- An immunohistochemical study of androgen, oestrogen and progesterone receptors in the vulva and vagina (1998) (130)
- Accelerated detection with prospective surveillance for cutaneous malignant melanoma in high-risk groups (1993) (123)
- A case-control study of melanomas of the soles and palms (Australia and Scotland) (1999) (121)
- A variant in FTO shows association with melanoma risk not due to BMI (2013) (120)
- Melanoma incidence and mortality in Scotland 1979–2003 (2007) (120)
- Association of MC1R Variants and Host Phenotypes With Melanoma Risk in CDKN2A Mutation Carriers: A GenoMEL Study (2010) (113)
- Experience of a public education programme on early detection of cutaneous malignant melanoma. (1988) (111)
- A randomized trial of adjuvant chemotherapy and immunotherapy in cutaneous melanoma. (1982) (110)
- A pooled analysis of melanocytic nevus phenotype and the risk of cutaneous melanoma at different latitudes (2009) (107)
- Adjuvant therapy with pegylated interferon alfa-2b versus observation in resected stage III melanoma: a phase III randomized controlled trial of health-related quality of life and symptoms by the European Organisation for Research and Treatment of Cancer Melanoma Group. (2009) (105)
- Genetic testing for melanoma. (2002) (104)
- The Effect on Melanoma Risk of Genes Previously Associated With Telomere Length (2014) (103)
- Use of NK1 C3 monoclonal antibody in the assessment of benign and malignant melanocytic lesions. (1984) (102)
- DNA repair gene polymorphisms and genetic predisposition to cutaneous melanoma. (2007) (95)
- Reasons for poor prognosis in British patients with cutaneous malignant melanoma. (1986) (95)
- Comparison between lentigo maligna melanoma and other histogenetic types of malignant melanoma of the head and neck. Scottish Melanoma Group. (1996) (91)
- CDKN2A germline mutations in U.K. patients with familial melanoma and multiple primary melanomas. (1998) (91)
- Development of melanocytic nevi in the first three years of life. (2000) (91)
- Quantitation of dendritic cells in normal and abnormal human epidermis using monoclonal antibodies directed against Ia and HTA antigens. (1983) (90)
- Long-term health risk to the skin of ultraviolet radiation. (2006) (90)
- Loss of β2 microglobulin from the cell surface of cutaneous malignant and premalignant lesions (1981) (88)
- Genome-wide association meta-analyses combining multiple risk phenotypes provides insights into the genetic architecture of cutaneous melanoma susceptibility (2020) (87)
- Validity of the histopathological criteria used for diagnosing dysplastic naevi. An interobserver study by the pathology subgroup of the EORTC Malignant Melanoma Cooperative Group. (1993) (85)
- Immunophenotyping of the cutaneous infiltrate and of the mononuclear cells in the peripheral blood in patients with atopic dermatitis. (1987) (82)
- Naevi in schoolchildren in Scotland and Australia (1994) (81)
- BENIGN NAEVI ASSOCIATED WITH HIGH RISK OF MELANOMA (1984) (79)
- The phototumorigenic potential of broad-band (270-350 nm) and narrow-band (311-313 nm) phototherapy sources cannot be predicted by their edematogenic potential in hairless mouse skin. (1995) (76)
- Long-Term Protective Effect of Mature DC-LAMP+ Dendritic Cell Accumulation in Sentinel Lymph Nodes Containing Micrometastatic Melanoma (2007) (76)
- Basal cell cytoplasmic autoantibodies in oral lichenoid reactions. (1995) (74)
- Intraoperative identification of sentinel lymph node in patients with malignant melanoma. (1997) (72)
- Prognostic models for subgroups of melanoma patients from the Scottish Melanoma Group database 1979-86, and their subsequent validation. (1995) (71)
- INITIAL EVENT IN MYCOSIS FUNGOIDES OF THE SKIN IS VIRAL INFECTION OF EPIDERMAL LANGERHANS CELLS (1981) (70)
- Prevalence of exon 15 BRAF mutations in primary melanoma of the superficial spreading, nodular, acral, and lentigo maligna subtypes. (2005) (70)
- Telomerase activity in melanoma and non-melanoma skin cancer (1999) (70)
- MALIGNANT MELANOMA IN SCOTLAND 1979-1983 (1985) (69)
- Effects of Ultraviolet Radiation on Human Health (2000) (68)
- Early diagnosis of infantile seborrhoeic dermatitis and atopic dermatitis—clinical features (1983) (68)
- Absence of exon 15 BRAF germline mutations in familial melanoma (2003) (65)
- A case-control study of possible causative factors in mycosis fungoides. (1987) (65)
- A Case-Control Study of Possible Causative Factors in Mycosis Fungoides (1987) (64)
- Localization of elevated transforming growth factor-alpha in psoriatic epidermis. (1990) (62)
- Genetic and environmental influences in the development of multiple primary melanoma. (1999) (62)
- Results of administering B.C.G. to patients with melanoma. (1974) (57)
- ‘This isn't what mine looked like’: a qualitative study of symptom appraisal and help seeking in people recently diagnosed with melanoma (2014) (57)
- Heterogeneity of chemosensitivity of metastatic cutaneous melanoma. (1999) (57)
- Soft‐Tissue Tumours and Tumour‐like Conditions (2008) (57)
- Different susceptibilities of melanoma cells to retinoic acid-induced changes in melanotic expression. (1988) (56)
- Cerebral metastases of cutaneous melanoma. (1997) (55)
- Multiple melanoma and atypical melanocytic naevi—evidence of an activated and expanded melanocytic system (1982) (54)
- Value of sentinel node status as a prognostic factor in melanoma: prospective observational study (2006) (52)
- Cellular immunity in human malignant melanoma and melanoma histology. (1973) (48)
- Changes in the incidence of cutaneous melanoma in the west of Scotland and Queensland, Australia: hope for health promotion? (2008) (47)
- Utility of adjuvant systemic therapy in melanoma (2009) (47)
- Multiple primary melanoma: risk factors and prognostic implications (1994) (46)
- Langerhans' cells and subtypes of human papillomavirus in cervical intraepithelial neoplasia. (1988) (46)
- Cutaneous malignant melanoma of the head and neck (1993) (46)
- Relation between phenotype and banal melanocytic naevi. (1987) (45)
- Melanoma in people aged 65 and over in Scotland, 1979-89. (1992) (44)
- Cellular fine structure in the invasive nodules of different histogenetic types of malignant melanoma (1978) (42)
- Cutaneous Lymphomas and Lymphocytic Infiltrates (2008) (42)
- Dapsone therapy for the acute inflammatory phase of ocular pemphigoid. (1992) (42)
- Juvenile plantar dermatosis: A new entity? (1976) (41)
- The learning curve for sentinel node biopsy in malignant melanoma. (2002) (41)
- An examination of the immunology of cancer patients (1976) (39)
- Cellular immunity to breast carcinoma and malignant melanoma. (1973) (38)
- Tamoxifen as a single agent for advanced melanoma in postmenopausal women. A phase II study of the EORTC Malignant Melanoma Cooperative Group (1992) (38)
- A multicentre phase II trial of vindesine in malignant melanoma. (1982) (38)
- Pregnancy and exogenous hormones in patients with cutaneous malignant melanoma. (1999) (38)
- Cutaneous malignant melanoma in Scotland. (1982) (38)
- Further evidence of the safety of tar in the management of psoriasis (1985) (38)
- Effect of maintenance chemotherapy in childhood on numbers of melanocytic naevi. (1992) (38)
- Lymphocyte abnormalities in mycosis fungoides (1976) (37)
- Proposed alternative terminology and subclassification of so called "dysplastic naevi". (1986) (36)
- Combination therapy for psoriasis with methotrexate and etretinate. (1986) (35)
- Serum anti‐tumour antibodies and auto‐antibodies in vitiligo (1975) (35)
- The pathogenesis of cutaneous malignant melanoma. (1983) (35)
- Hormone replacement therapy after surgery for stage 1 or 2 cutaneous melanoma (2004) (35)
- Balloon cell metastatic melanoma: an important differential in the diagnosis of clear cell tumours (1994) (34)
- Melanoma prevention and early detection. (1995) (33)
- Fine mapping of genetic susceptibility loci for melanoma reveals a mixture of single variant and multiple variant regions (2014) (32)
- SYNERGISTIC CARCINOGENIC POTENTIAL OF METHOTREXATE AND PUVA IN PSORIASIS (1983) (32)
- A monoclonal antibody technique to demonstrate an increase in Langerhans cells in cutaneous lesions of mycosis fungoides (1982) (32)
- The distribution and quantification of the Langerhans cell in normal human epidermis (1986) (31)
- Assessment of prognosis in patients with malignant melanoma. (1972) (31)
- Links between Exposure to Ultraviolet Radiation and Skin Cancer (1987) (31)
- A comparison of the anatomic distribution of cutaneous melanoma in two populations with different levels of sunlight: the west of Scotland and Queensland, Australia 1982–2001 (2007) (30)
- Cutaneous malignant melanoma, Scotland, 1979-89. The Scottish Melanoma Group. (1992) (30)
- The use of BELD combination chemotherapy (bleomycin, vindesine, CCNU, and DTIC) in advanced malignant melanoma (1985) (30)
- Comparison of five antimelanoma antibodies for identification of melanocytic cells on tissue sections in routine dermatopathology. (1989) (29)
- Effect of public education aimed at early diagnosis of malignant melanoma: cohort comparison study (2003) (29)
- Bone changes associated with oral retinoid therapy. (1989) (29)
- Juvenile Plantar Dermatosis—an 8‐year follow‐up of 102 patients (1987) (29)
- Biologic markers of sun exposure and melanoma risk in women: Pooled case–control analysis (2011) (28)
- Formalinized tumour cells in the leucocyte migration inhibition test. (1975) (28)
- Development of an alternative light source to lasers for photodynamic therapy: 3. Clinical evaluation in the treatment of pre-malignant non-melanoma skin cancer (1995) (28)
- Malignant melanoma of the head and neck in Scotland: an eight-year analysis of trends in prevalence, distribution and prognosis. (1987) (28)
- A comparison of the dermal lymphoid infiltrates in discoid lupus erythematosus and Jessner's lymphocytic infiltrate of the skin using the monoclonal antibody Leu 8 (1987) (27)
- Preliminary evidence for involvement of the tumour suppressor gene CHD5 in a family with cutaneous melanoma (2011) (27)
- Cutaneous malignancy in males treated with photochemotherapy (1990) (27)
- Modulation of melanoma cell adhesion to basement membrane components by retinoic acid. (1989) (27)
- A controlled study of gold contact hypersensitivity (1998) (26)
- Total and specific IgE levels in patients with atopic dermatitis (1979) (26)
- Dissociation of HLA heavy chain and light chain (β2 microglobulin) expression on the cell surface of cutaneous malignancies (1983) (26)
- Development and Validation of a Melanoma Risk Score Based on Pooled Data from 16 Case–Control Studies (2015) (26)
- A single centre's 10 year experience with isolated limb perfusion in the treatment of recurrent malignant melanoma of the limb. (1996) (25)
- The relationship between risk of death from clinical stage 1 cutaneous melanoma and thickness of primary tumour: no evidence for steps in risk. Scottish Melanoma Group. (1991) (25)
- Outcomes and pathological review of a cohort of children with melanoma (2005) (25)
- Interferon-α for atopic dermatitis (1990) (25)
- EORTC 18991 phase III trial: Long-term adjuvant pegylated interferon-α2b (PEG-IFN) versus observation in resected stage III melanoma: Long-term results at 7.6-years follow-up. (2011) (24)
- Clinical Dermatology: An Illustrated Textbook (1981) (23)
- Tumours of the Epidermis (1992) (23)
- Disorders of the Cutaneous Melanocyte (2008) (22)
- Chronic mucocutaneous candidiasis treated with transfer factor (1976) (22)
- HLA AND MYCOSIS FUNGOIDES (1976) (22)
- Cellular fine structure in the invasive nodules of different histogenetic types of malignant melanoma. (1979) (22)
- Measurement of daylight UVA in Glasgow. (1983) (21)
- Early recognition of malignant melanoma. (1986) (21)
- FORMALIN-FIXED TUMOUR CELLS IN THE LEUCOCYTE MIGRATION TEST (1973) (21)
- Report on consensus meeting of the EORTC melanoma group of educational needs for primary and secondary prevention of melanoma in Europe (1991) (21)
- The significance of conversion of skin reactivity to efficacy of bacillus Calmette-Guérin (BCG) vaccinations given immediately after radical surgery in stage II melanoma patients (2004) (21)
- Prevalence of gold contact hypersensitivity in the West of Scotland (1997) (21)
- The staphylococcal scalded skin syndrome in two elderly immunocompromised patients. (1987) (20)
- Cutaneous microscopy in vivo as an aid to preoperative assessment of pigmented lesions of the skin. (1972) (19)
- Tanning with ultraviolet A sunbeds. (1990) (19)
- VITILIGO PATTERNS SIMULATING AUTOIMMUNE AND RHEUMATIC DISEASES (1979) (19)
- Q‐switched ruby laser in the treatment of labial melanotic macules (1999) (19)
- Melphalan concentration and distribution in the tissues of tumour-bearing limbs treated by isolated limb perfusion. (1992) (19)
- Lupus erythematosus in association with finger‐clubbing (1973) (18)
- Serum lipid elevation during isotretinoin therapy for acne in the West of Scotland (1990) (18)
- Stage II melanoma in the west of Scotland, 1976-1985: prognostic factors for survival. (1991) (18)
- Melphalan in Isolated Limb Perfusion for Malignant Melanoma, Bolus or Divided Dose, Tissue Levels, the pH Effect (1990) (17)
- Assessment and use of a new skin hygrometer (1985) (17)
- The staphylococci. Importance of their control in the management of skin disease. (1993) (17)
- Re‐examining crude coal tar treatment for psoriasis (1992) (17)
- Incidence, mortality and survival in cutaneous malignant melanoma in Scotland 1979???1994: 260 (1997) (17)
- Cell-cell and cell-extracellular matrix interactions during melanoma cell invasion and metastasis. (1993) (16)
- Retinoic acid-induced inhibition of lung colonization and changes in the synthesis and properties of glycosaminoglycans of metastatic B16 melanoma cells. (1989) (16)
- The role of human melanoma cell ICAM-1 expression on lymphokine activated killer cell-mediated lysis, and the effect of retinoic acid (1999) (16)
- Risk of carcinogenicity in patients with psoriasis treated with methotrexate or PUVA singly or in combination. (1983) (16)
- Skin Cancer: An Illustrated Guide to the Aetiology, Clinical Features, Pathology and Management of Benign and Malignant Cutaneous Tumours (1989) (15)
- Sweet’s Syndrome (1974) (14)
- Health and the ozone layer. (1988) (14)
- Melanoma cell-derived factor stimulation of fibroblast glycosaminoglycan synthesis--the role of platelet-derived growth factor. (1999) (14)
- Severe reaction to diphosphonate: implications for treatment of Paget's disease. (1988) (14)
- Type IV collagen and laminin staining patterns in benign and malignant cutaneous lesions. (1989) (14)
- Risk factors for the development of primary cutaneous malignant melanoma. (2002) (13)
- The role of sunlight in the aetiology of cutaneous malignant melanoma (1981) (13)
- The M53I mutation in CDKN2A is a founder mutation that predominates in melanoma patients with Scottish ancestry (2007) (13)
- The relationship between immunological parameters and response to therapy in resistant oral candidosis (1978) (13)
- Distribution of HLA antigens in patients with mycosis fungoides. (1977) (13)
- Expression of p16, CD95, CD95L and Helix pomatia agglutinin in relapsing and nonrelapsing very thin melanoma (2007) (13)
- The Epidermis in Disease (1982) (13)
- Primary and secondary prevention of malignant melanoma (1996) (12)
- MANAGING THE DYSPLASTIC NAEVUS (1983) (12)
- Histological changes observed in the skin of patients with mycosis fungoides receiving photochemotherapy (1980) (12)
- Texture Features in the Classification of Melanocytic Lesions (1997) (12)
- The suitability of SunCheck® patches and Tanscan® cards for monitoring the sunburning effectiveness of sunlight (1993) (12)
- Melanoma and the dermatologist in the third millennium. (2000) (11)
- Out‐patient treatment of psoriasis: short contact and overnight dithranol therapy compared (1985) (11)
- The impact of immunohistochemistry on sentinel node biopsy for primary cutaneous malignant melanoma. (2003) (11)
- Prognostic evaluation of sentinel node biopsy: 357 (1997) (11)
- A Study of HLA Antigen Distribution in Families with Atopic Dermatitis (1979) (11)
- Paradoxical response of malignant melanoma to methotrexate in vivo and in vitro. (1983) (11)
- Intraoperative lymphatic mapping using patent blue V dye to identify nodal micrometastases in malignant melanoma (1994) (11)
- A multicentre 12‐week open study of a lipid‐soluble folate antagonist, piritrexim in severe psoriasis (1993) (11)
- European School of Oncology advisory report. Sun exposure, UVA lamps and risk of skin cancer. (1994) (11)
- Growth hormone levels in psoriasis (2004) (11)
- Tumor-directed cellular immunity in malignant melanoma and its modification by surgical treatment. (1973) (11)
- WHICH MOLES MATTER? THE ASSOCIATION BETWEEN MELANOCYTIC NAEVI AND MALIGNANT MELANOMATA (1981) (11)
- The use of paraffin‐processed tissue and the immunoperoxidase technique in the diagnosis of bullous diseases, lupus erythematosus and vasculitis (1982) (11)
- Generalized eruptive histiocytoma (1992) (10)
- The value of Nm23 expression as an independent prognostic indicator in primary thick melanoma (1996) (10)
- The effect of topical steroid application on natural killer cell activity (1989) (10)
- INTESTINAL PERMEABILITY AND ATOPIC DISEASE (1981) (9)
- Phase II studies of mitozolomide in melanoma, lung and ovarian cancer. (1989) (9)
- Pyoderma gangrenosum occurring 10 years after proctocolectomy for ulcerative colitis. (1986) (9)
- Plasma zinc in psoriatic in‐patients treated with local zinc applications (1980) (8)
- A case of focal dermal hypoplasia (1982) (8)
- Follicular mucinosis, mycosis fungoides, and acute myeloid leukemia. (1990) (8)
- Studies in Cutaneous Immunofluorescence (1980) (7)
- Studies in Cutaneous Immunofluorescence (1981) (7)
- Strategies to reduce mortality from cutaneous malignant melanoma (2004) (7)
- SYNTHETIC RETINOIDS FOR ACNE (1980) (7)
- The melanoma epidemic (1996) (7)
- p19 ANTIGEN IN SKIN AND LYMPH NODES OF PATIENT WITH ADVANCED MYCOSIS FUNGOIDES (1985) (7)
- Melanoma and other skin neoplasms (1995) (7)
- Interferon-alpha for atopic dermatitis. (1990) (6)
- A comparison of the rate of development of melanocytic naevi in infants in Scotland and Australia: 015 (1997) (6)
- Observational study of type of surgical training and outcome of definitive surgery for primary malignant melanoma (2002) (6)
- I. Sun exposure, UVA lamps and risk of skin cancer: Epidemiological studies (1994) (6)
- Indirect leukocyte migration assay in patients with malignant melanoma (1979) (6)
- Practical considerations of melanoma/skin cancer screening clinics. (1992) (6)
- The mechanism of tumour cell induced inhibition of human leucocyte migration. (1979) (6)
- Milne's Dermatopathology (1984) (6)
- A comparison of dosimetric methods in isolated limb perfusion with melphalan for malignant melanoma of the lower extremity. (1996) (6)
- Risk factors, diagnosis, and detection of melanoma. (1991) (6)
- Sweet's syndrome. A further case of acute febrile neutrophilic dermatosis. (1974) (5)
- A comparative study of the relative sensitivity and specificity of radiolabelled monoclonal antibody and computerised tomography in the detection of sites of disease in human malignant melanoma. (1989) (5)
- RISK FACTORS FOR MELANOMA (1989) (5)
- Melanoma and pregnancy (1991) (5)
- Early detection of malignant melanoma: observation on results of educational strategies. (1993) (5)
- Assessment of an anti-T-cell receptor variable region antibody panel in cutaneous T-cell lymphoma. (1994) (5)
- Thickness and delay in diagnosis of melanoma: how far can we go? (1999) (5)
- Reaction of the leukocytes of melanoma patients and control donors, including pregnant women, with melanoma- and fetus-derived materials (2004) (4)
- What are education and screening and diagnosis and prevention of melanoma achieving?: 14 (1993) (4)
- A case of follicular mucinosis progressing to mycosis fungoides (poster) (2002) (4)
- In vitro reaction of cancer patients and others to Bacillus Calmette‐Guérin (1980) (4)
- Report on consensus meeting of the EORTC Melanoma Group on educational needs for primary and secondary prevention of melanoma in Europe. Results of a workshop held under the auspices of the EEC Europe against cancer programme in Innsbruck, April 1991. (1991) (4)
- Mucocutaneous candidiasis responsive to transfer factor therapy. (1979) (4)
- Reasons for delay in primary treatment of British patients with malignant melanoma (1985) (4)
- Public and professional educational exercises on melanoma. (1992) (4)
- Cytotoxicity of etretinate and vindesine. (1985) (3)
- Genome-wide association meta-analyses combining multiple risk phenotypes provide insights into the genetic architecture of cutaneous melanoma susceptibility (2020) (3)
- Immunological abnormalities in patients with candidiasis and their relationship to severity of infection (1977) (3)
- A single centre prospective study of adjuvant isolated limb perfusion (ILP): 354 (1993) (3)
- Missed malignant melanoma (1986) (3)
- 1067 Analysis of the EORTC Melanoma Group 18952 randomized trial on 2 intermediate dose schedules of IFN-alpha2b compared with observation in 1388 patients with high risk melanoma stages IIB-III (2003) (3)
- THE LEUCOCYTE MIGRATION TECHNIQUE IN STUDIES OF TUMOR-DIRECTED CELLULAR IMMUNITY IN MALIGNANT MELANOMA (1976) (3)
- Partial characterisation of human melanoma cell-derived factors that stimulate fibroblast glycosaminoglycan synthesis. (1996) (3)
- Clinical Differential Diagnosis of Cutaneous Malignant Melanoma (1992) (3)
- Epidemiology of melanoma (1995) (3)
- Experience with the colony-forming (stem cell) assay of in vitro chemosensitivity in the management of patients with advanced malignant melanoma. (1984) (3)
- Sun and skin damage (1993) (3)
- Postoperative Depression ofTumour-directed Cell-mediated Immunity inPatients withMalignant Disease (1972) (3)
- Management of cutaneous T cell lymphoma (1994) (2)
- The Use of Isotretinoin in Rosacea (1984) (2)
- The Editor's Prologue 1988 (1988) (2)
- Publisher Correction: Novel pleiotropic risk loci for melanoma and nevus density implicate multiple biological pathways (2019) (2)
- Localized secondary telangiectasia in patients with thyroid disease (1973) (2)
- Effect of retinoic acid on plasminogen activator expression in human melanoma cells. (1999) (2)
- A prospective study of cutaneous changes which accompany bone marrow grafting (1984) (2)
- Growth hormone levels in psoriasis (2004) (2)
- Proceedings: Some aspects of the use of B.C.G. in the treatment of advanced malignant disease. (1974) (2)
- Clinical features of cutaneous melanoma and the role of Naevi as precursor lesions (1984) (2)
- Topical miconazole cream in infantile napkin dermatitis. (1979) (2)
- Changing tumour thickness in melanomas in Scotland 1979–89: 218 (1993) (2)
- A Clinical Trial of the Use of Tigason (Ro 10-9359) in Male Patients with Severe Acne Vulgaris (1981) (2)
- Comparative study of three methods of plastic embedding in diagnostic dermatopathology. (1985) (2)
- VI. What has been achieved by primary and secondary prevention campaigns (1994) (2)
- The unexpected sites of melanoma regional recurrences. (2006) (2)
- Results of WHO melanoma programme international study on computerized image analysis: 19 (1993) (2)
- ASSESSMENT OF PROGNOSIS IN MALIGNANT MELANOMA (1972) (2)
- Letter: HLA and mycosis fungoides. (1976) (2)
- Symposium: Chronic Mucocutaneous Candidiasis 1 : Mucocutaneous Candidiasis Responsive to Transfer Factor Therapy (1979) (2)
- O11 Rising levels of serum S100 protein precede other evidence of recurrence in patients with AJCC stage 3B malignant melanoma (1999) (2)
- Dissection of regional lymph nodes in cutaneous melanoma (1998) (2)
- The epidemiology of melanoma in the West: 003 (1997) (2)
- Healthy skin : the facts (1992) (2)
- Pentoxifylline-induced modulation of melanoma cell growth, adhesion and lymphokine activated killer cell-mediated lysis. (1999) (2)
- Melanoma and nonmelanoma skin cancer: Editorial overview (1991) (2)
- A case of facial diplegia associated with herpes simplex reactivation (1998) (2)
- Retinoic acid-induced inhibition of lung colonization and changes in the synthesis and properties of glycosaminoglycans of metastatic B 16 melanoma cells (2005) (1)
- Assessment of the efficacy of targeted radiotherapy using radioactive iodine 131 and 125 in the treatment of B16/F10 melanoma in a nude mice model (1994) (1)
- British Society for Investigative Dermatology Annual Meeting, University of Nottingham, 30 September to 1 October 1983 (1983) (1)
- Symposium: Chronic mucocutaneous candidiasis. (1979) (1)
- Diagnosis, detection, and staging of cutaneous malignant melanoma. (1990) (1)
- Melanoma and other skin neoplasms. (1990) (1)
- VALIDATION OF IN VITRO CHEMOSENSITIVITY TESTING IN MALIGNANT MELANOMA (1983) (1)
- Risk factor analysis of melanoma of the extremities (1997) (1)
- A single centre study of therapeutic isolated limb perfusion (ILP) using melphalan (1994) (1)
- UV radiation and melanoma (1993) (1)
- A study of IgE and RAST levels in patients with chronic atopic dermatitis (1978) (1)
- Malignant melanoma. A comparison of cellular fine structure in invasive nodules of different histogenetic type (1976) (1)
- Intraoperative lymphatic mapping using patient blue V dye to identify regional micrometastasis in limb malignant melanoma (1995) (1)
- Melanoma and other skin neoplasms. (1990) (1)
- Malignant melanoma and the Scottish Melanoma Group. (1986) (1)
- Clinical assessment of a new technique in identification of occult regional micrometastases in malignant melanoma (1994) (1)
- Critical Remarks on the Dysplastic Naevus Syndrome (1984) (1)
- Jejunal Biopsies in Bullous Pemphigoid (1972) (1)
- 13 Adjuvant treatment of high-risk malignant melanoma with ??; -interferon: a Scottish Melanoma Group study (1995) (1)
- Letter: Formalin-fixed tumour cells in the leukocyte migration test. (1973) (1)
- International Symposium: Skin Carcinogenesis in Man and in Experimental Models (1992) (1)
- A compact mercury vapour concentration meter (2016) (1)
- Immunological changes in cancer patients receiving BCG. (1977) (1)
- Topical econazole in cutaneous fungal infections. (1980) (0)
- Professor Neil Harrison Cox BSc, MB ChB, FRCP (1956–2009) (2010) (0)
- 23. The importance of lymphoscintigraphy for sentinel node biopsy for cutaneous melanoma of the head and neck (2002) (0)
- The use of the Psorilux 3050A machine in the management of psoriasis of the hands and feet (1980) (0)
- 30th Annual Meeting of the BACR & 4th Annual Meeting of ACP - 10-12 April 1989 (1989) (0)
- Pyoderma gangrenosum in infancy. (1982) (0)
- Evaluation and staging in the Scottish Dermatological Society mycosis fungoides register. (1977) (0)
- A case–control study of cutaneous viral and fungal infection, actinic keratoses and cutaneous malignancy in renal transplant patients (1983) (0)
- The treatment of subungual melanoma with isolated limb perfusion: a ten year experience (1997) (0)
- Results of a single centre prospective study of adjuvant isolated limb perfusion (ILP) (1994) (0)
- Beta 2-microglobulin changes in skin cancer. (1982) (0)
- A study of IgE and RAST levels in patients with chronic atopic dermatitis (1978) (0)
- Sunlamps and the risk of melanoma: Authors' reply (1988) (0)
- Melanoma in Scotland 1979 to 1993 (1993) (0)
- The management of cutaneous malignant melanoma * (1982) (0)
- Proceedings: cellular immunity to malignant melanoma. (1973) (0)
- Development and Validation of a Melanoma Risk Score Based on PooledData from 16 Case – Control Studies (2015) (0)
- Melanoma and other skin neoplasms Commentary (1994) (0)
- Abstracts of the Sixth International Conference on the Adjuvant Therapy of Malignant Melanoma (2007) (0)
- Proceedings: Immunity in patients with breast cancer. (1975) (0)
- Malignant melanomata: An aid to preoperative diagnosis (1972) (0)
- Response of Prof. Rona M. MacKie (1993) (0)
- Reply (1994) (0)
- Reply (1988) (0)
- Melanocytic naevi in children having received chemotherapy (1993) (0)
- [The monthly bibliographic selection: prophylactic adenectomy of a melanoma sentinel node]. (1999) (0)
- Re: Primary treatment of malignant melanoma (2017) (0)
- β2-Microglobulin changes in skin cancer (1982) (0)
- Correction to: Overlapping genetic architecture between Parkinson disease and melanoma (2020) (0)
- Novel pleiotropic risk loci for melanoma and nevus density implicate multiple biological pathways (2018) (0)
- Porphyria Cutanea Tarda and Hyperkeratosis (1972) (0)
- Not wanted at thirty-five. (1979) (0)
- Melanocytic nevus counts and melanoma. (1989) (0)
- Epidemiology, Precursors, and Markers of Malignant Melanoma (1988) (0)
- Melanoma--fifth world conference. (2001) (0)
- Changes in glycosaminoglycan synthesis and cellular adhesion associated with increassed metastatic potential of melanoma cells (1987) (0)
- S039 The epidemiology of melanoma in Scotland 1978–1994 (1997) (0)
- Editor's note (1988) (0)
- Reply (1983) (0)
- Reply (1977) (0)
- Reply to letter by Drs Gillis and Hole (1982) (0)
- Immunopathology of the Skin (1987) (0)
- Any questions: Ultraviolet light for psoriasis (1997) (0)
- A single-centre ten-year study of therapeutic isolated limb perfusion (ILP) using melphalan (1995) (0)
- Malignant melanoma in Scotland (1979-1983) (1986) (0)
- Comparative study ofthree methods ofplastic embedding indiagnostic dermatopathology (1985) (0)
- P30 The use of tyrosinase and melan A/MART specific reverse transcriptase polymerase chain reaction to detect melanoma cells in peripheral blood (1999) (0)
- Melanoma and other skin neoplasms. (1995) (0)
- Experience of isolated limb perfusion in the treatment of subungual melanoma (1994) (0)
- Dermatology: disorders of cutaneous pigmentation. (1978) (0)
- NOT WANTED AT THIRTY-FIVE (1979) (0)
- Prediction of Recurrent Melanoma by Variations in the Strength of Anti-Tumor Immunity (1979) (0)
- Immunology of malignant melanoma (1984) (0)
- Evidence to support the use of intravenous methotrexate in severe psoriasis (1983) (0)
- Keratinocytes produce potent fibroblast glycosaminoglycan-stimulating activities (1998) (0)
- Tumor thickness in melanoma. (1982) (0)
- Atlas of cutaneous laser surgery (1992) (0)
- Do dysplastic naevi exist and what is their significance?: 61 (1993) (0)
- Reply (1986) (0)
- The Physiology and Pathophysiology of the Skin (1985) (0)
- Laboratory of Biochemical Risk Analysis (1993) (0)
- Alpha 1-antitrypsin and alpha 1-antichymotrypsin in cutaneous histiocytic lesions and a comparison with lysozyme antibody staining. (1984) (0)
- A risk factor analysis of malignant melanoma of the extremities: 175 (1997) (0)
- Book Review: New Books: Viral Warts: Their Biology and Treatment (1982) (0)
- High counts of normal melanocytic naevi are a risk factor for cutaneous malignant melanoma (1985) (0)
- Who should be an author. (1983) (0)
- Erythemal response to different intensities and sources used in PUVA (2016) (0)
- families from three continents mutations: a GenoMEL study of melanoma-prone Features associated with germline CDKN2A (2007) (0)
- Publisher Correction: Novel pleiotropic risk loci for melanoma and nevus density implicate multiple biological pathways (2019) (0)
- Demonstration of α1-antitrypsin and α1-axantichymotrypsin in cutaneous histiocytic lesions and a comparison with lysozyme antibody staining (1984) (0)
- Summaries of Papers (1994) (0)
- Current trends in the management of recurrent malignant melanoma (1977) (0)
- Fundamentals of Skin Biopsy (1986) (0)
- Forward (1988) (0)
- Reply (1991) (0)
- Cytotoxicity of etietinate and vindesine (1986) (0)
- Missed malignant melanomas (1986) (0)
- A single-centre prospective study of isolated limb perfusion in the treatment of subungual melanoma (1995) (0)
- INV 1 The changing incidence of melanoma: who should be considered for adjuvant therapy (2007) (0)
- Research Snippets (2005) (0)
- Melanoma and other skin neoplasms: Editorial overview (1992) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Rona M. M. Mackie?
Rona M. M. Mackie is affiliated with the following schools:
